Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
TRL-1068 is a monoclonal antibody in clinical development as a non-traditional antimicrobial agent. It specifically targets biofilm-related infections (e.g., multi-resistant Pseudomonas aeruginosa infections). It is being evaluated in clinical trials alongside other anti-virulence therapies, bacteriophages, and innovative antibiotics to obtain better treatment options against resistant bacterial pathogens.
Romanos et al. 2025 Expert Opinion on Investigational Dru…